Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Doctor measuring patient's blood pressure | Image credit: Andrey Popov – stock.adobe.com
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes

November 19th 2024

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.

Young man frustrated with finances | Image credit: master1305 – stock.adobe.com
Young Adults With Low Incomes Have Higher Diabetes Mortality Risk

November 14th 2024

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers

November 13th 2024

AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com
Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

November 5th 2024

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com
How Neighborhood Social Needs Drive Diabetes Care Disparities

October 18th 2024

More News

COVID-19 Risk Demonstrates Importance of Keeping Diabetes Under Control
March 27th 2020

COVID-19 Risk Demonstrates Importance of Keeping Diabetes Under Control

Gianna Melillo
According to the CDC, individuals with diabetes may experience more serious complications from the novel coronavirus (COVID-19) than the general population.
Study Finds 1 in 10 Patients With Diabetes May Be Overtreated
March 24th 2020

Study Finds 1 in 10 Patients With Diabetes May Be Overtreated

Matthew Gavidia
Researchers found that 1 in 10 patients with diabetes initially hospitalized for treatment of common medical conditions was discharged with intensified diabetes medications, with nearly half unlikely to benefit due to limited life expectancy or already having an optimal blood glucose level.
Study Finds Diabetes Pay-for-Performance Program Reduces All-Cause Mortality
March 23rd 2020

Study Finds Diabetes Pay-for-Performance Program Reduces All-Cause Mortality

Alison Rodriguez
Diabetes pay-for-performance programs may reduce all-cause mortality in patients with type 2 diabetes (T2D).
AJMC® in the Press, March 20, 2020
March 20th 2020

AJMC® in the Press, March 20, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Air Pollution Alters Gut Microbiome, Increasing Risks for Diabetes, Obesity, Study Says
March 17th 2020

Air Pollution Alters Gut Microbiome, Increasing Risks for Diabetes, Obesity, Study Says

Gianna Melillo
Exposure to air pollutants alters the composition of gut microbiota, which increases the risk of obesity, diabetes, gastrointestinal disorders, and other chronic illnesses, according to a study published in Environment International.
Artificial Intelligence for the Diagnosis of Diabetic Retinopathy: An Interview With Michael D. Abramoff, MD, PhD
March 17th 2020

Artificial Intelligence for the Diagnosis of Diabetic Retinopathy: An Interview With Michael D. Abramoff, MD, PhD

Ida Delmendo
Michael D. Abramoff, MD, PhD, is the Robert C. Watzke, MD Professor of ophthalmology and visual sciences at the University of Iowa Carver College of Medicine. He is also a professor of electrical and computer engineering and a professor of biomedical engineering at the University of Iowa. Abramoff’s research interests include how autonomous artificial intelligence (AI) can be used to improve the lives of patients, with a focus on autonomous AI-based diagnostic and quantification algorithms for retinal disease. He is the founder and executive chairman of IDx Technologies, which developed IDx-DR, an FDA-authorized autonomous AI diagnostic system for the detection of diabetic retinopathy and macular edema. An editor from The American Journal of Managed Care® recently conducted a question-and-answer session with Abramoff regarding the use of AI in the diagnosis of diabetic retinopathy.
Improving Quality of Care for Patients With Type 2 Diabetes: An Interview With Robert A. Gabbay, MD, PhD, FACP
March 12th 2020

Improving Quality of Care for Patients With Type 2 Diabetes: An Interview With Robert A. Gabbay, MD, PhD, FACP

What We're Reading: FDA Fast Tracks Jardiance; Experts Warn of Restrictive Abortion Laws; Alcoholics Anonymous Proves Effective
March 12th 2020

What We're Reading: FDA Fast Tracks Jardiance; Experts Warn of Restrictive Abortion Laws; Alcoholics Anonymous Proves Effective

AJMC Staff
The FDA granted a fast track designation to Jardiance (empagliflozin) for treatment of chronic kidney disease; a new review in the New England Journal of Medicine urges physicians to prepare for self-managed abortion complications; Alcoholics Anonymous is more effective than other common abstinence treatments.
Lessons From a 25-Year Study of Type 1 Diabetes
March 12th 2020

Lessons From a 25-Year Study of Type 1 Diabetes

JDRF
From funding innovative research to advocating for government action to providing a support structure for our community, no other organization does more to fight type 1 diabetes (T1D) than JDRF.
New CMS Model Aims to Lower Insulin Costs for Seniors
March 11th 2020

New CMS Model Aims to Lower Insulin Costs for Seniors

Gianna Melillo
Today CMS announced the Part D Senior Savings Model, allowing Medicare Part D prescription drug plans to offer plan choices that provide a range of insulins to beneficiaries, at a maximum $35 copay per 30-day supply throughout the benefit year.
Site Logo
March 10th 2020

Cost-effectiveness of Diabetes Treatment Sequences to Inform Step Therapy Policies

Anna Hung, PharmD, PhD Bhavna Jois, BS Amy Lugo, PharmD Julia F. Slejko, PhD
This study assesses the cost-effectiveness of adding a sodium-glucose cotransporter 2 inhibitor versus switching to a glucagon-like peptide-1 receptor agonist in patients with diabetes on metformin and a dipeptidyl peptidase-4 inhibitor.
FDA Issues New Draft Guidance on T2D Medication Safety Trials
March 9th 2020

FDA Issues New Draft Guidance on T2D Medication Safety Trials

Gianna Melillo
The FDA announced a new draft guidance to consider broader evaluations beyond cardiovascular outcomes trials for type 2 diabetes (T2D) medications.
American Diabetes Association Unveils New Engagement Platform
March 8th 2020

American Diabetes Association Unveils New Engagement Platform

Gianna Melillo
The American Diabetes Association (ADA) recently created a new part of its website, the Engagement Platform, designed to track legislation of interest to consumers.
AJMC® in the Press, March 6, 2020
March 6th 2020

AJMC® in the Press, March 6, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Site Logo
March 6th 2020

Payer Effects of Personalized Preventive Care for Patients With Diabetes

Brant Morefield, PhD Lisa Tomai, MS Vladislav Slanchev, PhD Andrea Klemes, DO
We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
Metabolic Health, Weight Affect Diabetes Risk in Postmenopausal Women
March 4th 2020

Metabolic Health, Weight Affect Diabetes Risk in Postmenopausal Women

Gianna Melillo
A study on data from the Women’s Health Initiative found good metabolic health and effective weight management can minimize diabetes risk in postmenopausal women. The study, published in Menopause, the journal of The North American Menopause Society, aimed to determine the relationship between metabolic weight categories with incident diabetes in postmenopausal women aged 50 to 79 years.
AJMC® in the Press, February 28, 2020
February 28th 2020

AJMC® in the Press, February 28, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Abbott, DexCom Partner With Insulet to Improve Diabetes Management Technology
February 25th 2020

Abbott, DexCom Partner With Insulet to Improve Diabetes Management Technology

Gianna Melillo
Abbott recently announced a partnership with Insulet Corporation to integrate its glucose-sensing technology with an automated insulin delivery system for patients with diabetes. Specifically, Abbott’s FreeStyle Libre system will become compatible with Insulet’s Omnipod Horizon, in an effort to “offer personalized automated insulin delivery and care for people living with diabetes.”
FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD
February 24th 2020

FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD

Gianna Melillo
The FDA approved Eli Lilly’s dulaglutide (Trulicity) for the reduction of major adverse cardiovascular events in adults with type 2 diabetes (T2D), with and without established cardiovascular disease (CVD), according to a press release.
This Week in Managed Care: February 21, 2020
February 21st 2020

This Week in Managed Care: February 21, 2020

This week, top managed care stories included an additional setback for Medicaid work rules; another study finding more benefits from SGLT2 inhibitors; researchers finding unwanted end-of-life care causes stress.
Improving Cardiovascular Outcomes Among Patients With Type 2 Diabetes: An Interview With Nihar Desai, MD, MPH
February 21st 2020

Improving Cardiovascular Outcomes Among Patients With Type 2 Diabetes: An Interview With Nihar Desai, MD, MPH

6 Connected Patient Challenge Finalists to Compete in Live Pitch-Off
February 18th 2020

6 Connected Patient Challenge Finalists to Compete in Live Pitch-Off

Samara Rosenfeld
The 6 finalists will pitch their innovations at Google’s campus February 27 for a chance to win up to $50,000 in in-kind services from Boston Scientific and Google.
SGLT2 Inhibitors Benefit All Patients with T2D, Regardless of CVD Diagnosis
February 17th 2020

SGLT2 Inhibitors Benefit All Patients with T2D, Regardless of CVD Diagnosis

Gianna Melillo
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors leads to cardiovascular benefits in all patients with type 2 diabetes (T2D), according to a study recently published in the Journal of the American Heart Association.
Going Paleo? Study Says It's No Better Than Other Diets for Glucose, Insulin Regulation
February 17th 2020

Going Paleo? Study Says It's No Better Than Other Diets for Glucose, Insulin Regulation

Jared Kaltwasser
There’s not much research available comparing the Paleolithic diet to other popular nutritional plans. A new study sought to scour existing data to see the Paleolithic diet’s effect on glucose and insulin regulation. The data showed no significant impact.
PAPER OF THE WEEK: The Links Between Metabolic Syndrome and Mental Illness
February 16th 2020

PAPER OF THE WEEK: The Links Between Metabolic Syndrome and Mental Illness

Mary Caffrey
The 2007 paper examined the elevated risks for cardiovascular disease and type 2 diabetes for patients who have schizophrenia or bipolar disorder.
A Qualitative Look at Feeling "Lost" During Pregnancy With Type 1 Diabetes
February 15th 2020

A Qualitative Look at Feeling "Lost" During Pregnancy With Type 1 Diabetes

Alison Rodriguez
Results showed that managing T1D becomes more intense during pregnancy and in the months that follow childbirth. This is due to the need to be even more vigilant than usual in monitoring blood glucose levels and dosing insulin, tasks the women performed mostly themselves, but which can also be performed by other healthcare professionals.
First Nations Women of Canada Have Higher Diabetes Rates, Study Finds
February 11th 2020

First Nations Women of Canada Have Higher Diabetes Rates, Study Finds

Gianna Melillo
Data collected between 1995 and 2014 show prevalence and incidence of diabetes are substantially higher in First Nations people in Canada compared to other people in Ontario, according to a study published in the Canadian Medical Association Journal.
Site Logo
February 11th 2020

In 1 Illinois District, Residents' Main Concern: Healthcare, Drug Costs, Legislator Says

Allison Inserro
Atul Grover, MD, PhD, the executive vice president for the Association of American Medical Colleges, sat down with Representative Lauren Underwood, D-Illinois, for a conversation about her healthcare-related efforts during her first year in Congress representing people from a suburban rural district 2 hours from Chicago.
Circadian Clock Closely Linked to T2D, Study Finds
February 5th 2020

Circadian Clock Closely Linked to T2D, Study Finds

Gianna Melillo
Researchers discovered a link between circadian clock disturbances in pancreatic cells and type 2 diabetes (T2D), according a study published in Proceedings of the National Academy of Sciences.
Scientists Capture High-Resolution Imaging of Glucagon-Like Peptide-1 Receptors
January 27th 2020

Scientists Capture High-Resolution Imaging of Glucagon-Like Peptide-1 Receptors

Gianna Melillo
For the first time, scientists obtained high-definition images of glucagon-like peptide-1 receptors, enabling future research into treatments for type 2 diabetes, according to a study published in Nature Communications.
<1
...
131415161718192021
...
97>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo